ADPT — Adaptive Biotechnologies Share News
0.000.00%
- $3.35bn
- $3.27bn
- $276.98m
Adaptive Biotechnologies Corp reports results for the quarter ended in March - Earnings Summary
Brief: Adaptive Biotechnologies Q1 EPS USD -0.33
Adaptive Biotechnologies Corp expected to post a loss of 34 cents a share - Earnings Preview
Brief: Adaptive Biotechnologies Says On April 1, CFO Tycho Peterson Submitted His Resignation
Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: Adaptive Biotechnologies Q4 EPS USD -0.48
Adaptive Biotechnologies Corp expected to post a loss of 33 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Apple, Globe Life, Health Catalyst
Brief: Adaptive Biotechnologies Q3 EPS USD -0.35
Adaptive Biotechnologies Corp expected to post a loss of 34 cents a share - Earnings Preview
Adaptive Biotechnologies Corp reports results for the quarter ended in June - Earnings Summary
Brief: Adaptive Biotechnologies Q2 EPS USD -0.33
Adaptive Biotechnologies Corp expected to post a loss of 35 cents a share - Earnings Preview
Brief: Adaptive Biotechnologies Announces FDA Acceptance Of Genentech’S Investigational New Drug Application For The First Neoantigen-Directed T-Cell Therapy Product In Oncology
U.S. RESEARCH ROUNDUP-Albemarle, Cable One, Southwest Airlines
Adaptive Biotechnologies Corp reports results for the quarter ended in March - Earnings Summary
Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
Adaptive Biotechnologies Corp expected to post a loss of 38 cents a share - Earnings Preview